Yih-Ing Hser

Quick facts

Phase 3 pipeline

• Sublingual buprenorphine-naloxone · Pain
  Buprenorphine is a partial opioid agonist that binds to opioid receptors, while naloxone is an opioid antagonist that blocks opioid receptors.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Yih-Ing Hser portfolio CI brief
• Yih-Ing Hser pipeline updates RSS